NEW YORK (Reuters Health) – There appears to be no increase or decrease in mortality among arthritis patients treated with anti-tumor necrosis factor agents, when compared to standard non-biologic treatment, British data indicate.
Writing in Arthritis & Rheumatism published online July 26, Dr. Kemme...